Paper7214366
Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
Waseda N and 3 others. Cancer Res, 1981. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. Papers, record 7214366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7214366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Receptors, Estrogen | Major topic |
| Receptors, Progesterone | Major topic |
| Tamoxifen | Major topic |
| Cell Nucleus | |
| Cytosol | |
| Humans | |
| Kinetics | |
| Temperature | |
| Time Factors |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41386485 | The effects of tamoxifen and its metabolites on circulating estrogen metabolites among pre- and postmenopausal women. | Steroids | 2026 | https://conductscience.org/library/papers/41386485 | PubMed |
| 28134770 | Review: Receptor Targeted Nuclear Imaging of Breast Cancer. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28134770 | PubMed |
| 22331216 | Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione. | J Nucl Med | 2012 | https://conductscience.org/library/papers/22331216 | PubMed |
| 9635844 | The effect of 3-week tamoxifen treatment on oestrogen receptor levels in primary breast tumours: a flow cytometric study. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9635844 | PubMed |
| 8750530 | Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8750530 | PubMed |
| 8611373 | Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8611373 | PubMed |
| 8554983 | Oestrogen receptor: a stable phenotype in breast cancer. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8554983 | PubMed |
| 8491762 | Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8491762 | PubMed |
| 8251648 | Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8251648 | PubMed |
| 8250600 | Effects of tamoxifen on human breast cancer cells in vitro. | Arch Gynecol Obstet | 1993 | https://conductscience.org/library/papers/8250600 | PubMed |
| 7171839 | Variability of steroid receptors in multiple biopsies of breast cancer: effect of systemic therapy. | Breast Cancer Res Treat | 1982 | https://conductscience.org/library/papers/7171839 | PubMed |
| 3437623 | A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues. | Jpn J Surg | 1987 | https://conductscience.org/library/papers/3437623 | PubMed |
| 2931228 | The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitro. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/2931228 | PubMed |
| 2151369 | Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer. | Breast Cancer Res Treat | 1990 | https://conductscience.org/library/papers/2151369 | PubMed |
| 1756259 | Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer. | Breast Cancer Res Treat | 1991 | https://conductscience.org/library/papers/1756259 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7214366
GET https://conductscience.org/api/papers/v1/7214366/authors